Menu
Not yet recruiting NCT07485465

Lymphoedema Diagnosis and Treatment

Observational Lymphedema Artificial Intelligence (AI)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: a domain-specific, custom-trained large language model for the differential diagnosis and treatment planning of lymphedema, lipedema, and venous insufficiency.
Who it may be relevant to
Registry conditions: Lymphedema, Artificial Intelligence (AI). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Role of Chat GPT in the Diagnosis and Treatment of Lymphedema

Overview

A domain-specific, custom-trained large language model for the differential diagnosis and treatment planning of lymphedema, lipedema, and venous insufficiency.

Detailed description

The differential diagnosis of lower limb swelling remains problematic in clinical practice, as lymphedema, lipedema, and peripheral venous disease often present with similar features. Therefore, we developed LymphedemaGPT, a GPT-5-based clinical assistant designed to help practitioners navigate these diagnostic complexities.

LymphedemaGPT was designed to analyze structured patient data to extract clinical summaries, present possible diagnoses with percentage probabilities, create differential diagnosis tables, suggest additional diagnostic tests, and generate evidence-based treatment plans.

LymphedemaGPT's responses are based on seven scientific publications uploaded to the system, in addition to the Sleigh BC \& Manna B (2023) and Rockson approaches. Owing to this resource integration, the model can provide more reliable and consistent recommendations aligned with evidence-based medicine principles based on current guidelines and scientific publications.

Extensive prompt engineering techniques were applied to optimize the diagnostic and therapeutic accuracy of LymphedemaGPT.

The model is programmed to prioritize the questioning phase until a diagnosis is confirmed. In the initial responses, only structured anamnesis questions were asked, and after sufficient information was collected, systematic analysis and treatment planning were initiated. The response flow was designed as follows: (1) history collection, (2) preliminary assessment, (3) additional questioning (if necessary), and (4) systematic analysis and treatment planning when sufficient data were obtained.

The following patient data was presented to LymphedemaGPT in a structured format:

Demographic data: Age, gender, height, weight Medical history: Additional illnesses, medications used, habits (smoking, alcohol) Complaint characteristics: Time of onset, affected area, symptoms (pain, heaviness, numbness, tingling, stiffness, limited movement, weakness, etc.) Physical examination findings: Stemmer sign, swelling change with elevation, skin findings Medical history: History of infection, history of surgery, history of malignancy (radiotherapy, chemotherapy, lymph node dissection, type of cancer) Imaging: Doppler ultrasonography and lymphoscintigraphy results, if available

LymphedemaGPT was asked to respond in the following 12-part standard format: (1) Clinical Summary, (2) Possible Diagnoses (% probability), (3) Differential Diagnosis, (4) Recommended Diagnostic Tests, (5) Treatment Plan, (6) Patient Education and Follow-up, (7) Red Flags, (8) references, (9) Level of Evidence and Confidence Score, (10) Ethical Note, (11) Data Summary (JSON/CSV), and (12) Analysis Timestamp.

The performance of LymphedemaGPT was evaluated by experienced physicians based on the following eight criteria:

1. Accuracy and adequacy of clinical summary 2. Accuracy of primary diagnosis 3. Accuracy of differential diagnosis table 4. Appropriateness of recommended diagnostic tests 5. Concordance of treatment plan with current guidelines 6. Appropriateness of compression class/exercise-diet recommendations 7. Adequacy of red flags 8. Overall clinical utility

Each criterion was scored using a 5-point Likert scale: 5 = excellent/completely suitable, 4 = good/significantly suitable, 3 = moderate/partially suitable, 2 = poor/inadequate, and 1 = very poor/not suitable. The maximum score for each case was 40 (8 criteria × 5 points), and the minimum score was 8.

Two experienced physicians independently performed the evaluation. The evaluators were physical medicine and rehabilitation specialists experienced in the management of lymphedema and lipedema, and they independently performed the scoring.

Interventions

  • Other a domain-specific, custom-trained large language model for the differential diagnosis and treatment planning of lymphedema, lipedema, and venous insufficiency
    LymphedemaGPT was designed to analyze structured patient data to extract clinical summaries, present possible diagnoses with percentage probabilities, create differential diagnosis tables, suggest additional diagnostic tests, and generate evidence-based treatment plans.

Primary outcome measures

  • Diagnostic accuracy rate [Time frame: 1 hour]
  • Treatment adequacy rate [Time frame: 1 hour]
  • Average criterion score [Time frame: 1 hour]
Secondary outcome measures (1)
  • Overall performance score [Time frame: 1 hour]

Eligibility criteria

Inclusion criteria

  • Patients over the age of 18
  • Clinical diagnosis of lymphoedema
  • Clinical diagnosis of lipoedema
  • Clinical diagnosis of venous insufficiency

Exclusion criteria

  • Lack of medical history
  • Lack of demographic data
  • Lack of clinical data and
  • Lack of imaging methods

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Turkey (Türkiye) · 1 center
  • Istanbul Fatih Sultan Mehmet Training and Research Hospital — Istanbul

Publications

  • Leypold T, Lingens LF, Beier JP, Boos AM. Integrating AI in Lipedema Management: Assessing the Efficacy of GPT-4 as a Consultation Assistant. Life (Basel). 2024 May 20;14(5):646. doi: 10.3390/life14050646. PMID 38792666
  • Eldaly AS, Avila FR, Torres-Guzman RA, Maita K, Garcia JP, Serrano LP, Forte AJ. Artificial intelligence and lymphedema: State of the art. J Clin Transl Res. 2022 Jun 1;8(3):234-242. eCollection 2022 Jun 29. PMID 35813896
  • Wojcik S, Rulkiewicz A, Pruszczyk P, Lisik W, Pobozy M, Domienik-Karlowicz J. Beyond ChatGPT: What does GPT-4 add to healthcare? The dawn of a new era. Cardiol J. 2023;30(6):1018-1025. doi: 10.5603/cj.97515. Epub 2023 Oct 13. PMID 37830256
  • Mesko B. The Impact of Multimodal Large Language Models on Health Care's Future. J Med Internet Res. 2023 Nov 2;25:e52865. doi: 10.2196/52865. PMID 37917126

Identifiers

NCT: NCT07485465 · FSMLYMPHEDEMA

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗